Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies with Cbl-b inhibitor compounds

Combination therapies with Cbl-b inhibitor compounds

US Patent 12016860 · Granted Jun 25, 2024

Estimated economic value: $25,703,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CBL inhibitors and compositions for use in adoptive cell therapy2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating can2020
Administration of polynucleotide toll-like receptor 9 agonists for treating canc2019
Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists fo2018
Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists fo2018
Human toll-like receptor inhibitors and methods of use thereof2018
Methods and compositions for inhibition of immune responses and autoimmunity2016
Methods of treatment using TLR7 and/or TLR9 inhibitors2016
Human toll-like receptor inhibitors and methods of use thereof2016
Transgenic mice expressing human toll-like receptor 82015
Methods and compositions for inhibition of immune responses and autoimmunity2015